Ansel Health
Venture Round in 2024
Ansel Health is a Delaware-based company established in 2019, developing a health insurance platform for employers to enhance employee benefits with simple supplemental health plans. It offers cash payments upon diagnosis for over 13,000 conditions, utilizing data-driven tools and automated claim processing.
1010data
Acquisition in 2023
1010data, Inc. is a data management and analytics company that specializes in providing big data discovery and sharing solutions for both business and technical users. Founded in 1999 and headquartered in New York, the company offers a range of products, including its flagship 1010data Big Data Discovery platform, which allows users to analyze data directly where it is stored. Its suite of solutions also includes advanced analytics capabilities, data sharing and monetization options, and industry-specific applications that help organizations leverage their enterprise data alongside third-party data. The company provides a cloud-based Analytical Platform as a Service (APaaS), which features an analytical database, user-friendly interfaces for reporting and analysis, and integration capabilities for various data sources. 1010data serves a diverse clientele across multiple sectors, including retail, financial services, healthcare, and government, helping organizations enhance their operational efficiency and drive strategic growth.
SymphonyAI Sensa-NetReveal
Acquisition in 2022
SymphonyAI Sensa-NetReveal specializes in risk management and fraud detection, focusing on regulatory compliance and the prevention of financial crime. The company collaborates with financial institutions worldwide to optimize risk management operations through advanced data management and analytical capabilities. Its services include investigation management, workflow, and reporting, which are designed to combat financial crime, fraud, and cyber attacks in the banking, financial, and insurance sectors. By leveraging digital and AI technologies, SymphonyAI Sensa-NetReveal aims to enhance the effectiveness of its clients' risk management strategies and contribute to a more secure financial environment.
ReTech Labs
Acquisition in 2021
ReTech Labs is an IT company that specializes in providing innovative retail technology solutions. It develops artificial intelligence, robotics, and computer vision technologies aimed at simplifying operations and enhancing revenue growth for retail and consumer packaged goods (CPG) clients. The company's technology portfolio features a machine learning platform that automates store processes and addresses inefficiencies in physical retail environments. Additionally, ReTech Labs offers a private brand management ecosystem and a comprehensive store management platform that utilizes artificial intelligence, sensors, and real-time data analysis. These tools enable retailers and CPG teams to effectively manage on-shelf availability, resolve out-of-stock issues, and ensure compliance with planograms, pricing, and promotions.
Ansel Health
Series A in 2021
Ansel Health is a Delaware-based company established in 2019, developing a health insurance platform for employers to enhance employee benefits with simple supplemental health plans. It offers cash payments upon diagnosis for over 13,000 conditions, utilizing data-driven tools and automated claim processing.
Ansel Health
Seed Round in 2020
Ansel Health is a Delaware-based company established in 2019, developing a health insurance platform for employers to enhance employee benefits with simple supplemental health plans. It offers cash payments upon diagnosis for over 13,000 conditions, utilizing data-driven tools and automated claim processing.
Ansel Health
Seed Round in 2020
Ansel Health is a Delaware-based company established in 2019, developing a health insurance platform for employers to enhance employee benefits with simple supplemental health plans. It offers cash payments upon diagnosis for over 13,000 conditions, utilizing data-driven tools and automated claim processing.
TeraRecon
Acquisition in 2020
TeraRecon, Inc. is a prominent provider of enterprise medical image management and visualization solutions for healthcare organizations globally. Established in 1997 and headquartered in Durham, North Carolina, with additional offices in Japan, Germany, Massachusetts, and Brazil, TeraRecon specializes in advanced imaging technologies that enhance image processing and 3D visualization capabilities. The company offers a diverse range of products, including its flagship solution, iNtuition, which supports neuroimaging, oncology, volumetric cardiac imaging, and vascular planning. Other notable offerings include iNtuitionREVIEW, AI Sync technology, iNtuitionCLOUD, and iNtuitionEMV, which facilitate seamless integration and sharing of medical images and data. TeraRecon is recognized for its innovative advancements in medical imaging, having received multiple awards for its contributions to the field, and continues to focus on improving clinical care through its cutting-edge technologies and training services.
ConcertAI
Series B in 2020
ConcertAI is a Boston-based company established in 2018 that specializes in developing a suite of medical research tools focused on oncology. The company aims to enhance care-based oncology research and data analytics through its integrated real-world data and AI-driven solutions. ConcertAI’s offerings are designed to improve oncology health outcomes and clinical trial efficiency by utilizing custom patient surveys. This enables pharmaceutical companies to assess existing treatments and advance the development of new therapies. By facilitating the generation of real-world evidence and insights, ConcertAI assists project teams, medical experts, and scientists in delivering impactful research and innovations in cancer care.
SymphonyAI
Acquisition in 2019
SymphonyAI is a leading enterprise AI SaaS company offering productized AI applications for high-value use cases in retail/CPG, financial services, industrial, enterprise IT, and media sectors. With over 2,000 global customers, SymphonyAI empowers businesses with insights to address challenges and drive growth. Headquartered in Palo Alto, California, the company employs a global workforce of 2,500 professionals across 26 countries.
SymphonyAI Sensa
Acquisition in 2019
SymphonyAI Sensa specializes in advanced crime detection services tailored for financial institutions globally. Utilizing a unique blend of artificial intelligence and machine learning, Sensa identifies criminal activities that often go undetected by conventional systems. The company's technology has demonstrated significant results, including up to an 81-fold improvement in risk-to-alert ratios, a 263% increase in suspicious activity reports, and a reduction of false positives by as much as 77%. Sensa also provides predictive insights that enhance operational efficiencies by pinpointing genuine anomalies in existing data. Its user-friendly interface ensures that results are fully explainable, meeting regulatory requirements while enabling data analysts to uncover patterns through innovative topological data analysis techniques.
Symphony EYC
Acquisition in 2018
Symphony EYC, formed in 2012 from the merger of Aldata and EYC, serves as a strategic partner to major retail and consumer brands, as well as wholesale and distribution organizations. The company specializes in customer engagement programs, utilizing advanced analytics to analyze, model, and segment customer data. Symphony EYC designs comprehensive customer databases, reporting tools, and metric marts to support its clients in adopting customer-centric strategies. With a workforce of over 600 employees, the company caters to more than 1,000 clients and operates in over 25,000 stores across the Americas, Europe, and Asia. Its offerings include business plans, presentations, and training, all aimed at enhancing customer engagement and optimizing retail and distribution performance.
Precision Health AI
Series A in 2017
Precision Health AI is a platform technology company focused on applications of AI to Oncology. Serving Pharma, Life Sciences, Providers, and Payers PH.AI combines modern AI technology with best in class oncology data with a focus on improving outcomes and driving value based care.